Patients with surgery-related complications from a previous weight loss surgery, such as ulcers, vomiting, and acid reflux
Composition and Formulation Details 2.1 Active Ingredient: Semaglutide 2.2 Inactive Ingredients and Excipients Excipients stabilize the formulation and maintain sterility
Semaglutide slows gastric emptying, enhances satiety signals to the brain, and reduces hunger, thereby helping patients consume fewer calories and achieve sustainable weight loss
Discovery of efficacious Pseudomonas aeruginosa -targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model
(NEJM, 2023), Retatrutide achieved approximately 24% mean weight reduction at 12 mg at 48 weeks
FARXIGA has also been studied in adult patients with type 2 diabetes mellitus and moderate renal impairment